Check out your Company Bowl for anonymous work chats.
We are excited and proud to announce we have signed an agreement to acquire and construct an office building in the heart of downtown Portsmouth, New Hampshire. The property will provide space for Novocure’s growing employee base in Portsmouth, and house a world-class training and development center. “Portsmouth is an important part of our history,” said our Executive Chairman William Doyle. “With this investment, we are proudly demonstrating that Portsmouth, and the talented people in the New Hampshire medtech community, will continue to be an integral part of our future.”
We have entered into a clinical trial collaboration agreement with Roche to develop our therapy together with Roche’s anti-PD-L1 therapy in metastatic pancreatic ductal adenocarcinoma. Pancreatic ductal adenocarcinoma is the most common type of #pancreaticcancer.
We are proud to share that we are #6 on the Business NH Magazine list of the 2021 Best Places to Work in New Hampshire! See what makes working at Novocure special!
Today, we reported financial results for the second quarter of 2021. Our quarterly net revenues of $133.5 million present 15% growth versus the second quarter of 2020 with 79% gross margin. We invested a record $50 million in research and development initiatives across brain, thoracic and abdominal programs. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer. #earnings
Our patients trust us as an integral part of their cancer care team. We trust ourselves and our colleagues to act with integrity and accountability as we use our individual strengths to work together efficiently and effectively in pursuit of our patient-forward mission. #corevalues #Novocurevalues #WeAreNovocure #patientforward #fromdayoneforward
Here at Novocure, it takes courage to innovate. We stand alongside our patients and stand up for them by challenging the status quo. #corevalues #Novocurevalues #WeAreNovocure #patientforward #fromdayoneforward
Patients and their families are the heart of our mission. Our passion for making a difference in the lives of cancer patients fuels us in our day-to-day work and guides us in our decision-making. #corevalues #Novocurevalues #WeAreNovocure #patientforward #fromdayoneforward
Nick is a husband, father and grandfather. He’s an entrepreneur and a horse expert. Nick wears many hats, one being #patient. May is #BTAM. #wHATisGBM #BTSM
Our founders created a different way to fight cancer. We channel that founding spirit into our science, business and patient relationships to deliver innovative and proven solutions designed to advance cancer care. #corevalues #Novocurevalues #WeAreNovocure #patientforward #fromdayoneforward
We reported financial results for the first quarter 2021, highlighting continued commercial strength despite changes in patterns of care in some regions driven by the COVID-19 pandemic, as well as continued progress across the company’s clinical and product development programs. #earnings https://bit.ly/3t1BdND
